Jin-Gyu Lee
Direttore/Membro del Consiglio presso Institut Pasteur Korea Research Foundation
Provenienza dei contatti di primo grado di Jin-Gyu Lee
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Institut Pasteur Korea Research Foundation
Institut Pasteur Korea Research Foundation BiotechnologyHealth Technology Institut Pasteur Korea Research Foundation provides research and development for the treatment of infectious and chronic diseases. It develops a technology-based approach to therapeutic development through cellular models, high content screening and medicinal chemistry. The company was founded on December 29, 2003 and is headquartered in Seongnam, South Korea.
10
| Private Company | Biotechnology | 10 |
South Korea Ministry of Science, ICT & Future Planning
1
| Government | General Government | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Jin-Gyu Lee tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous The Institut Pasteur is a private non-profit foundation which contributes to the prevention and treatment of disease, through research, education, and public health activities. The firm was founded in 1887, and is based in Paris. | Investment Trusts/Mutual Funds | President Chief Administrative Officer | |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member | |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Miscellaneous Commercial Services | Director/Board Member | |
National Information Society Agency
National Information Society Agency Information Technology ServicesTechnology Services National Information Society Agency provides information and communications (ICT) policies and technologies. Its business divisions are National Information Technology (IT) Policy Group, Electronic Government Group, ICT Service Policy Division, Smart Network Division, Digital Culture Division, Digital Inclusion Policy Division, Global IT Cooperation Division, Privacy Protection Policy Division, Open Data Center, Big Data Strategy Center, Electronic Government Global Academy, and Internet Addiction Counseling Center. Its services include developing plans for national informatization policies and new agenda, maintaining and improving services in the electronic government website, developing plans for building infrastructure for the hyper-connected society and strategies for future network development, and establishing the master plan and policies for personal information protection. The company was founded in 1984 and is headquartered in Daegu, South Korea. | Information Technology Services | Director/Board Member | |
KAINOS MEDICINE, INC. | Biotechnology | Corporate Officer/Principal | |
University of Illinois | College/University | Doctorate Degree | |
National OncoVenture | Chief Executive Officer | ||
University of Oklahoma | College/University | Doctorate Degree | |
Seoul National University | College/University | Corporate Officer/Principal | |
Ecole Nationale d'Administration | College/University | Undergraduate Degree | |
Rarecells Diagnostics SAS
Rarecells Diagnostics SAS Packaged SoftwareTechnology Services Rarecells Diagnostics SAS is a French company passionate about saving lives by detecting and eliminating cancer at its start. The company is based in Paris, France and was founded by Patrizia Paterlini-Bréchot, who has been the CEO since incorporation. The company believes that accurate, early cancer detection has the potential to save millions of lives. Rarecells Diagnostics has developed the ISET blood filtration technology, which enables cell culture to generate xenograph of avatars. The company is currently conducting three clinical studies to evaluate the performance of their dedicated ISET-based assay to allow early detection of prostate cancer. The company is also developing a multi-cancer test for early cancer diagnosis and is working with researchers to propel care forward. | Packaged Software | Director/Board Member | |
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Biotechnology | Director/Board Member | |
ScreenCell SA
ScreenCell SA Miscellaneous Commercial ServicesCommercial Services ScreenCell SA provides access to circulating rare cells. It offers rare cell isolation solutions for medical and research applications. The company was founded by Patrizia Paterlini-Brechot, Ian Jones and Christian Brechot on April 11, 2001 and is headquartered in Sarcelles, France. | Miscellaneous Commercial Services | Founder | |
Compagnie Merieux Alliance SAS
Compagnie Merieux Alliance SAS Investment Trusts/Mutual FundsMiscellaneous Compagnie Mérieux Alliance SAS owns shares and interests in firms that manufactures, sells, and distributes medicines and other pharmaceutical products. The company is headquartered in Lyon, France. | Investment Trusts/Mutual Funds | Chief Tech/Sci/R&D Officer | |
European Personalised Medicine Association | Director/Board Member | ||
Fondation Ophtalmologique Adolphe de Rothschild
Fondation Ophtalmologique Adolphe de Rothschild Hospital/Nursing ManagementHealth Services Fondation Ophtalmologique Adolphe de Rothschild is a specialized hospital in Paris, FR that focuses on treating all pathologies related to the head and neck for both adults and children. The hospital has a pharmacy that ensures the supply of medicines and medical devices. The hospital also has a clinical research service that serves as a one-stop-shop for investigators and industrial or academic partners. The hospital is supported by the Edmond de Rothschild Foundations, which offer a Medical Fellowship program to support talented and promising young practitioners in their hospital-university dynamic. The CEO of the French company is Julien Gottsmann. | Hospital/Nursing Management | Director/Board Member | |
Fondation Mérieux | Investment Trusts/Mutual Funds | Director/Board Member | |
BIOMÉRIEUX | Medical Specialties | Director/Board Member | |
Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree | |
Hopital Necker-Enfants Malades | Corporate Officer/Principal | ||
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
TRANSGENE | Biotechnology | Director/Board Member | |
South Korea Ministry of Public Safety & Security | General Government | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
Francia | 13 |
Corea del Sud | 6 |
Stati Uniti | 5 |
Svizzera | 2 |
Lussemburgo | 2 |
Settori
Consumer Services | 6 |
Health Technology | 5 |
Miscellaneous | 4 |
Commercial Services | 4 |
Health Services | 3 |
Posizioni
Director/Board Member | 19 |
Corporate Officer/Principal | 6 |
President | 4 |
Doctorate Degree | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Contatti più connessi
Insiders | |
---|---|
Christian Brechot | 16 |
In-Chul Kim | 4 |
Christophe Mauriet | 3 |
Uh-Taek Oh | 3 |
Sung-Joo Kang | 3 |
Byoung Kwon Oh | 1 |
Jin-Keon Pai | 1 |
Man-Seong Park | 1 |
Hyuk Lee | 1 |
Pierre-Marie Girard | 1 |
Gye Dong Choi | 1 |
- Borsa valori
- Insiders
- Jin-Gyu Lee
- Connessioni Società